http://www.msnbc.msn.com/id/6876523/Clinic offers embryonic stem cells to publicAction likely to be a boost for scientific community
Updated: 2:01 p.m. ET Jan. 27, 2005
WASHINGTON - A human genetics clinic said on Thursday it had developed 18 new lines of disease-carrying embryonic stem cells and was offering them to researchers eager to study their potential for treating inherited diseases.
The action could be a small boost for scientists who have been stymied by strict federal limitations on stem-cell research, including a ban on federal funding for development of new lines of embryonic stem cells or for research using new lines.
Although lines of normal stem cells have been previously made available, the new batches are the first of diseased cells to be publicly released, said Dr. Yury Verlinsky, chief executive officer of the Reproductive Genetics Institute.
They could be used to study a range of serious inherited human diseases including a form of anemia called thalassemia, Fanconi anemia, and the brain-destroying Huntington disease, he said.
more:
http://www.msnbc.msn.com/id/6876523/